Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 2 (2005), Issue 3 (March)

1. Dehydroascorbic acid normalizes several markers of oxidative stress and inflammation in acute hyperglycemic focal cerebral ischemia in the rat.
   Neurochem Int, 46(5): 399-407. [Abstract] [Full-text]
2. Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?
   Am J Hematol, 78(3): 216-20. [Abstract] [Full-text]
3. Subjective visual vertical in pitch and roll in right hemispheric stroke.
   Stroke, 36(3): 588-91. [Abstract] [Full-text]
4. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke.
   Stroke, 36(3): 607-12. [Abstract] [Full-text]
5. Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: a community-based tri-racial cross-sectional survey.
   Stroke, 36(3): 551-6. [Abstract] [Full-text]
6. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies.
   Stroke, 36(3): 567-77. [Abstract] [Full-text]
7. Soluble platelet glycoprotein V is a marker of thrombosis in patients with ischemic stroke.
   Stroke, 36(3): e17-9. [Abstract] [Full-text]
8. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults.
   Stroke, 36(3): 533-9. [Abstract] [Full-text]
9. A description of Canadian and United States physician reimbursement for thrombolytic therapy administration in acute ischemic stroke.
   Stroke, 36(3): 682-7. [Abstract] [Full-text]
10. Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress.
    Stroke, 36(3): 670-2. [Abstract] [Full-text]
11. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
    Stroke, 36(3): 602-6. [Abstract] [Full-text]
12. Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis.
    Stroke, 36(3): 673-5. [Abstract] [Full-text]
13. Performance of the PHQ-9 as a screening tool for depression after stroke.
    Stroke, 36(3): 635-8. [Abstract] [Full-text]
14. Depression among caregivers of stroke survivors.
    Stroke, 36(3): 639-43. [Abstract] [Full-text]
15. Motor impairment and recovery in the upper limb after stroke: behavioral and neuroanatomical correlates.
    Stroke, 36(3): 625-9. [Abstract] [Full-text]
16. Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke Trial.
    Stroke, 36(3): 630-4. [Abstract] [Full-text]
17. Public awareness of warning symptoms, risk factors, and treatment of stroke in northwest India.
    Stroke, 36(3): 644-8. [Abstract] [Full-text]
18. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.
    JAMA, 293(9): 1082-8. [Abstract] [Full-text]
19. Lacunar stroke in patients with intermittent claudication.
    Acta Neurol Scand, 111(4): 253-7. [Abstract] [Full-text]
20. Exercise leads to faster postural reflexes, improved balance and mobility, and fewer falls in older persons with chronic stroke.
    J Am Geriatr Soc, 53(3): 416-23. [Abstract] [Full-text]
21. Submassive pulmonary embolism and paradoxical embolic stroke treated with percutaneous rheolytic thrombectomy and closure of the patent foramen ovale.
    Catheter Cardiovasc Interv, 64(3): 356-60. [Abstract] [Full-text]
22. Side differences in cerebrovascular accidents after cardiac surgery: a statistical analysis of neurologic symptoms and possible implications for anatomic mechanisms of aortic particle embolization.
    J Thorac Cardiovasc Surg, 129(3): 591-8. [Abstract] [Full-text]
23. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
    J Neuroimaging, 15(2): 188-92. [Abstract] [Full-text]
24. Dotlike hemosiderin spots are associated with past hemorrhagic strokes in patients with lacunar infarcts.
    J Neuroimaging, 15(2): 157-63. [Abstract] [Full-text]
25. Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease.
    J Neuroimaging, 15(2): 129-37. [Abstract] [Full-text]
26. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.
    Circ Res, 96(4): 412-8. [Abstract] [Full-text]
27. Does acupuncture help stroke patients become more independent?
    J Altern Complement Med, 11(1): 175-7. [Abstract] [Full-text]
28. Supernumerary phantom limb after stroke.
    Postgrad Med J, 81(953): e2. [Abstract] [Full-text]
29. Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.
    Int J Cardiol, 99(2): 269-75. [Abstract] [Full-text]
30. Long term outcome of transcranial bypass.
    Eur J Vasc Endovasc Surg, 29(4): 342-4. [Abstract] [Full-text]
31. Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats.
    Brain Res, 1038(1): 50-8. [Abstract] [Full-text]
32. Regional expression of constitutive and inducible transcription factors following transient focal ischemia in the neonatal rat: influence of hypothermia.
    Brain Res, 1038(1): 11-21. [Abstract] [Full-text]
33. Sequential cohort study of Dacron patch closure following carotid endarterectomy.
    Br J Surg, 92(3): 316-21. [Abstract] [Full-text]
34. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
    J Public Health (Oxf), 27(1): 85-92. [Abstract] [Full-text]
35. Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke.
    Am J Hypertens, 18(2): 65S-72S. [Abstract] [Full-text]
36. The depth of microembolic signal direction change corresponds with vessel anatomy.
    Cerebrovasc Dis, 19(3): 186-91. [Abstract] [Full-text]
37. Trends in five-year survival and risk of recurrent stroke after first-ever stroke in the Perth Community Stroke Study.
    Cerebrovasc Dis, 19(3): 179-85. [Abstract] [Full-text]
38. Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack.
    Cerebrovasc Dis, 19(3): 171-8. [Abstract] [Full-text]
39. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
    Cerebrovasc Dis, 19(3): 165-70. [Abstract] [Full-text]
40. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke.
    Cerebrovasc Dis, 19(3): 157-64. [Abstract] [Full-text]
41. Increased oxidative protein and DNA damage but decreased stress response in the aged brain following experimental stroke.
    Neurobiol Dis, 18(3): 432-40. [Abstract] [Full-text]
42. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance.
    Neurosci Lett, 377(3): 206-11. [Abstract] [Full-text]
43. Improved posthypoxic recovery in vitro on treatment with drugs used for secondary stroke prevention.
    Neuropharmacology, 48(4): 558-65. [Abstract] [Full-text]
44. The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.
    Basic Clin Pharmacol Toxicol, 96(4): 316-24. [Abstract] [Full-text]
45. Defining stroke risk in children with sickle cell anaemia.
    Br J Haematol, 128(6): 751-66. [Abstract] [Full-text]
46. Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities.
    Pediatr Radiol, 35(3): 223-8. [Abstract] [Full-text]
47. TCD in sickle cell disease: an important and useful test.
    Pediatr Radiol, 35(3): 229-34. [Abstract] [Full-text]
48. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler.
    Pediatr Radiol, 35(3): 242-8. [Abstract] [Full-text]
49. Severe trismus as a complication of cerebrovascular accident: a case report.
    Arch Phys Med Rehabil, 86(3): 594-5. [Abstract] [Full-text]
50. Continuous monitoring of upper-limb activity in a free-living environment.
    Arch Phys Med Rehabil, 86(3): 541-8. [Abstract] [Full-text]
51. Skilled nursing facility rehabilitation and discharge to home after stroke.
    Arch Phys Med Rehabil, 86(3): 442-8. [Abstract] [Full-text]
52. Muscle sympathetic nerve activity during isometric exercise in patients with cerebrovascular accidents.
    Arch Phys Med Rehabil, 86(3): 436-41. [Abstract] [Full-text]
53. The relationship between mean flow velocity and functional and neurologic parameters of ischemic stroke patients undergoing rehabilitation.
    Arch Phys Med Rehabil, 86(3): 427-30. [Abstract] [Full-text]
54. The validity of a road test after stroke.
    Arch Phys Med Rehabil, 86(3): 421-6. [Abstract] [Full-text]
55. Team functioning and patient outcomes in stroke rehabilitation.
    Arch Phys Med Rehabil, 86(3): 403-9. [Abstract] [Full-text]
56. Effects of mental practice on affected limb use and function in chronic stroke.
    Arch Phys Med Rehabil, 86(3): 399-402. [Abstract] [Full-text]
57. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    J Neurol Sci, 229: 275-84. [Abstract] [Full-text]
58. Aspirin resistance in stroke: 2004.
    J Neurol Sci, 229: 163-9. [Abstract] [Full-text]
59. Noninfarct vascular dementia and Alzheimer dementia spectrum.
    J Neurol Sci, 229: 27-36. [Abstract] [Full-text]
60. Contemporary linkages between EMG, kinetics and stroke rehabilitation.
    J Electromyogr Kinesiol, 15(3): 229-39. [Abstract] [Full-text]
61. Carotid endarterectomy in octogenarians: does increased age indicate "high risk?".
    J Vasc Surg, 41(2): 231-7. [Abstract] [Full-text]
62. Examination of sex as an independent risk factor for adverse events after carotid endarterectomy.
    J Vasc Surg, 41(2): 223-30. [Abstract] [Full-text]
63. Long-term results of carotid stenting are competitive with surgery.
    J Vasc Surg, 41(2): 213-21; discussion 221-2. [Abstract] [Full-text]
64. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
    Arch Neurol, 62(3): 403-8. [Abstract] [Full-text]
65. Neurologic worsening during the acute phase of ischemic stroke.
    Arch Neurol, 62(3): 393-7. [Abstract] [Full-text]
66. Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS.
    Arch Neurol, 62(3): 386-90. [Abstract] [Full-text]
67. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.
    Cancer Epidemiol Biomarkers Prev, 14(3): 643-50. [Abstract] [Full-text]
68. Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption.
    Pharmacotherapy, 25(2): 303-7. [Abstract] [Full-text]
69. American Heart Association and American Stroke Association national survey of stroke risk awareness among women.
    Circulation, 111(10): 1321-6. [Abstract] [Full-text]
70. Functional magnetic resonance imaging and diffusion tensor imaging in a case of central poststroke pain.
    J Pain, 6(3): 208-12. [Abstract] [Full-text]
71. Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?
    Heart, 91(4): 423-4. [Abstract] [Full-text]
72. Different effects of blood pressure on mortality from stroke subtypes depending on BMI levels: a 19-year cohort study in the Japanese general population--NIPPON DATA80.
    J Hum Hypertens, 19(4): 285-91. [Abstract] [Full-text]
73. Consequences of increased neuromotor noise for reaching movements in persons with stroke.
    Exp Brain Res, 162(1): 70-7. [Abstract] [Full-text]
74. Prediction of outcome in new-born infants with arterial ischaemic stroke using diffusion-weighted magnetic resonance imaging.
    Neuropediatrics, 36(1): 12-20. [Abstract] [Full-text]
75. Clinical significance of detection of multiple acute brain infarcts on diffusion weighted magnetic resonance imaging.
    J Neurol Neurosurg Psychiatry, 76(4): 514-8. [Abstract] [Full-text]
76. Comparison of Bobath based and movement science based treatment for stroke: a randomised controlled trial.
    J Neurol Neurosurg Psychiatry, 76(4): 503-8. [Abstract] [Full-text]
77. Alteplase and ischaemic stroke: have new reviews of old data helped?
    Lancet Neurol, 4(4): 249-53. [Abstract] [Full-text]
78. Expression of neurocan after transient middle cerebral artery occlusion in adult rat brain.
    Brain Res, 1037(1): 194-9. [Abstract] [Full-text]
79. Incidence of stroke is related to carotid IMT even in the absence of plaque.
    Atherosclerosis, 179(2): 325-31. [Abstract] [Full-text]
80. Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat.
    Acta Anaesthesiol Scand, 49(4): 488-93. [Abstract] [Full-text]
81. Prevention of brain infarction by postischemic administration of histidine in rats.
    Brain Res, 1039(1): 220-3. [Abstract] [Full-text]
82. Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia.
    Brain Res, 1039(1): 203-6. [Abstract] [Full-text]
83. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.
    Am J Cardiol, 95(7): 881-2. [Abstract] [Full-text]
84. Canceling out both the real and the spectral lines.
    Brain Cogn, 57(3): 226-35. [Abstract] [Full-text]
85. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis.
    Liver Int, 25(2): 331-6. [Abstract] [Full-text]
86. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.
    Blood, 105(7): 2685-90. [Abstract] [Full-text]
87. Stroke in surgery of the arteriosclerotic descending thoracic aortic aneurysms: influence of cross-clamping technique of the aorta.
    Eur J Cardiothorac Surg, 27(4): 622-5. [Abstract] [Full-text]
88. Simultaneous multi-section perfusion CT and CT angiography for the assessment of acute ischemic stroke.
    Acta Neurochir (Wien), 147(4): 383-91; discussion 391-2. [Abstract] [Full-text]
89. How can a patient blind to radial motion discriminate shifts in the center-of-motion?
    J Comput Neurosci, 18(1): 55-66. [Abstract] [Full-text]
90. Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
    Biol Res Nurs, 6(4): 281-8. [Abstract] [Full-text]
91. Reliability of gait performance tests in men and women with hemiparesis after stroke.
    J Rehabil Med, 37(2): 75-82. [Abstract] [Full-text]
92. Relation between stimulation characteristics and clinical outcome in studies using electrical stimulation to improve motor control of the upper extremity in stroke.
    J Rehabil Med, 37(2): 65-74. [Abstract] [Full-text]
93. Clinical and administrative outcomes during publicly-funded inpatient stroke rehabilitation based on a case-mix group classification model.
    J Rehabil Med, 37(1): 45-52. [Abstract] [Full-text]
94. Controlled study of neuroprosthetic functional electrical stimulation in sub-acute post-stroke rehabilitation.
    J Rehabil Med, 37(1): 32-6. [Abstract] [Full-text]
95. Cross-cultural validity of functional independence measure items in stroke: a study using Rasch analysis.
    J Rehabil Med, 37(1): 23-31. [Abstract] [Full-text]
96. Prevalence and risk factors for stroke in Type 2 diabetic patients in Taiwan: a cross-sectional survey of a national sample by telephone interview.
    Diabet Med, 22(4): 477-82. [Abstract] [Full-text]
97. Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat.
    J Cereb Blood Flow Metab, 25(4): 421-6. [Abstract] [Full-text]
98. Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
    J Cereb Blood Flow Metab, 25(4): 451-9. [Abstract] [Full-text]
99. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice.
    J Cereb Blood Flow Metab, 25(4): 431-9. [Abstract] [Full-text]
100. Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake.
     J Cereb Blood Flow Metab, 25(4): 513-9. [Abstract] [Full-text]
101. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress.
     Hypertension, 45(4): 786-92. [Abstract] [Full-text]
102. Hypoadiponectinemia is associated with ischemic cerebrovascular disease.
     Arterioscler Thromb Vasc Biol, 25(4): 821-6. [Abstract] [Full-text]
103. Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients.
     J Neurol Sci, 231(1): 13-8. [Abstract] [Full-text]
104. Alzheimer's disease with and without cerebral infarcts.
     J Neurol Sci, 231(1): 3-11. [Abstract] [Full-text]
105. Subcortical lesions after transient thread occlusion in the rat: T2-weighted magnetic resonance imaging findings without corresponding sensorimotor deficits.
     J Magn Reson Imaging, 21(4): 340-6. [Abstract] [Full-text]
106. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure.
     Pediatr Cardiol, 26(1): 56-61. [Abstract] [Full-text]
107. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
     Ann Emerg Med, 45(4): 377-84. [Abstract] [Full-text]
108. Modern anesthesia and peroperative monitoring methods reduce per- and postoperative mortality during transient occlusion of the middle cerebral artery in rats.
     Brain Res Brain Res Protoc, 14(3): 181-90. [Abstract] [Full-text]
109. A novel method of detecting rCBF with laser-Doppler flowmetry without cranial window through the skull for a MCAO rat model.
     Brain Res Brain Res Protoc, 14(3): 165-70. [Abstract] [Full-text]
110. Metabolic penumbra of acute brain infarction: a correlation with infarct growth.
     Ann Neurol, 57(4): 495-504. [Abstract] [Full-text]
111. Intracranial arterial dolichoectasia and small-vessel disease in stroke patients.
     Ann Neurol, 57(4): 472-9. [Abstract] [Full-text]
112. Sleep and stroke.
     Semin Neurol, 25(1): 19-32. [Abstract] [Full-text]
113. A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.
     Nitric Oxide, 12(3): 141-9. [Abstract] [Full-text]
114. Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke.
     Am J Hypertens, 18(3): 379-84. [Abstract] [Full-text]
115. Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging.
     Radiology, 235(1): 177-83. [Abstract] [Full-text]
116. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
     N Engl J Med, 352(13): 1305-16. [Abstract] [Full-text]
117. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.
     Nat Genet, 37(4): 435-40. [Abstract] [Full-text]
118. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts.
     Stroke, 36(4): 891-901. [Abstract] [Full-text]
119. Postacute C-reactive protein levels are elevated in cervical artery dissection.
     Stroke, 36(4): e42-4. [Abstract] [Full-text]
120. Determinants of quality of life in stroke survivors and their informal caregivers.
     Stroke, 36(4): 803-8. [Abstract] [Full-text]
121. A pilot study of normobaric oxygen therapy in acute ischemic stroke.
     Stroke, 36(4): 797-802. [Abstract] [Full-text]
122. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
     N Engl J Med, 352(13): 1293-304. [Abstract] [Full-text]
123. Study of the relationship between social deprivation and outcome after stroke.
     Stroke, 36(4): 815-9. [Abstract] [Full-text]
124. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats.
     Stroke, 36(4): 853-8. [Abstract] [Full-text]
125. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.
     Stroke, 36(4): 782-6. [Abstract] [Full-text]
126. Identification of embolic stroke patterns by diffusion-weighted MRI in clinically defined lacunar stroke syndromes.
     Stroke, 36(4): 757-61. [Abstract] [Full-text]
127. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke.
     Stroke, 36(4): 746-50. [Abstract] [Full-text]
128. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction.
     Stroke, 36(4): 768-72. [Abstract] [Full-text]
129. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes.
     Stroke, 36(4): 830-5. [Abstract] [Full-text]
130. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor.
     Stroke, 36(4): 847-52. [Abstract] [Full-text]
131. Blood pressure control and risk of stroke: a population-based prospective cohort study.
     Stroke, 36(4): 725-30. [Abstract] [Full-text]
132. Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion.
     Stroke, 36(4): 869-71. [Abstract] [Full-text]
133. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients.
     Stroke, 36(4): 731-6. [Abstract] [Full-text]
134. A simple 3-item stroke scale: comparison with the National Institutes of Health Stroke Scale and prediction of middle cerebral artery occlusion.
     Stroke, 36(4): 773-6. [Abstract] [Full-text]
135. Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis: multicenter experience from the Interventional Management of Stroke study.
     Stroke, 36(4): 865-8. [Abstract] [Full-text]
136. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network.
     Stroke, 36(4): 809-14. [Abstract] [Full-text]
137. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
     Stroke, 36(4): 880-90. [Abstract] [Full-text]
138. William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors.
     Stroke, 36(4): 875-9. [Abstract] [Full-text]
139. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview.
     Stroke, 36(4): 777-81. [Abstract] [Full-text]
140. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting.
     Stroke, 36(4): 787-91. [Abstract] [Full-text]
141. Cardiac power during exercise and the risk of stroke in men.
     Stroke, 36(4): 820-4. [Abstract] [Full-text]
142. Recovery from aphasia after hemicraniectomy for infarction of the speech-dominant hemisphere.
     Stroke, 36(4): 825-9. [Abstract] [Full-text]
143. Acute treatment for ischemic stroke in 2004.
     Emerg Radiol, 11(2): 83-6. [Abstract] [Full-text]
144. Advanced imaging application for acute ischemic stroke.
     Emerg Radiol, 11(2): 77-82. [Abstract] [Full-text]

© 2004-2008 Stroke Research Today. All Rights Reserved.